Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant

Sponsors and Collaborators
Mayo Clinic
Alexion Pharmaceuticals

Contact
Cindy M. Groettum
507-266-8725
[email protected]

Principal Investigator
Mark Stegall, MD, Mayo Clinic


Continue Reading

ClinicalTrials.gov Identifier
NCT01106027